Labcorp, a laboratory services company, agreed to acquire BioReference Health's select assets from OPKO Health, a multinational biopharmaceutical and diagnostics company, for $237.5m. "Labcorp is committed to building on the excellent customer service that physicians and health systems have come to expect from BioReference Health, while expanding access and convenience for patients across the country. We look forward to working with the BioReference Health team to ensure a smooth transition following the close of the transaction. Combined with Labcorp's expertise and scale, we will help achieve better health outcomes for patients," Mark Schroeder, Labcorp Executive Vice President and President of Diagnostics Laboratories and Chief Operations Officer.